Infectious Disease III - Antifungals and Antivirals Flashcards
MOA of amphotericin B
binds to ergosterol, altering membrane permeability causing cell death
spectrum of amphotericin B
broad spectrum - covers Mucor, yeasts, aspergillus and other molds
dose of conventional amphotericin B should not exceed:
1.5 mg/kg/day
typical dose of liposomal amphotericin B
3-6 mg/kg/day
side effects of all amphotericin B formulations (though much less so with liposomal)
1) infusion related reactions - fever, rigors, malaise, HA
2) hypokalemia
3) hypomagnesemia
4) nephrotoxicity
How are side effects/infusion reactions of amphotericin B mitigated?
pre-infusion with diphenhydramine and acetaminophen, fluids before and after
Patients on which cardiac medication should have electrolytes very closely monitored in light of potential hypokalemia with amphotericin B?
digoxin
MOA of flucytosine
converted to fluorouracil intracellularly and competes for uracil incorporation into DNA
place in therapy of flucytosine
combination with amphotericin B in invasive candida or cryptococcal infections
normal dosing of flucytosine
50-150 mg/kg/day PO in 4 divided doses
CrCl cutoff for flucytosine renal adjustment
40 mL/min
frequency doubles (eg doses per day halve) at 20, 10 and below 10 dose after HD
main side effect of flucytosine
myelosuppression (dose-related, results in neutropenia, anemia, thrombocytopenia)
others include increase SCr, BUN, bili, hypoglycemia, hypokalemia
class side effects/properties of azole antifungals
increased LFTs, QT prolongation (except isavuconazonium)
all are moderate 3A4 inhibitors - various other inhibitions with each drug
azoles MOA
decrease ergosterol synthesis and cell membrane formation
itraconazole is contraindicated in patients with which disease state?
heart failure